Oviva Therapeutics

Focus: Oviva Therapeutics is a pre-revenue biotech company founded in 2022 focused on menopause delay through anti-müllerian hormone-like activity. The company operates in the emerging women's health endocrinology space with a highly specialized therapeutic approach.

Endocrinology Women's Health

Profile data last refreshed 23h ago · AI intelligence enriched 1w ago

Open Jobs

About Oviva Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Oviva Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Oviva programme

Type 2 Diabetes Treated With Insulin

N/A

Clinical Trials (1)

NCT06119204SAFE-LCD Trial, for Insulin-treated Adults Living With Type 2 Diabetes

N/A

Help build intelligence for Oviva Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage opportunity in underserved women's health space with novel mechanism of action targeting menopause delay
Ground-floor position at a 2022-founded company allows shaping organizational culture and clinical strategy from inception
Intersection of endocrinology and women's health represents growing pharma investment area with significant unmet patient need

Watch Out For

No active clinical trials reported and no disclosed funding limit visibility into development timeline and runway
Zero current job openings and minimal public presence suggest early stealth-mode operations with limited hiring momentum
Pre-revenue stage with undisclosed capitalization creates uncertainty regarding financial stability and long-term career trajectory

Generated by Claude from Oviva Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

smartphone-assisted dietary coaching

Overweight

N/A

Clinical Trials (1)

NCT02694614Weight-loss Treatment Through Smartphone-assisted Dietary Coaching

N/A

Total diet replacement

Type2diabetes

N/A

Clinical Trials (1)

NCT05648903The Transform Type 2 Diabetes Study

N/A

Total Diet Replacement

Type 2 Diabetes

N/A

Clinical Trials (1)

NCT05626842The DR-EAM Type 2 Diabetes Study

N/A

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Founded: 2022

Portfolio: 4 clinical trials

Top TAs: Metabolic Diseases

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Metabolic Diseases

4 pipeline

Marketed

Pipeline